Valo Health
PrivateLast Round
Strategic
Jan 8, 2025
Est. Valuation
$2.8B
Total Funding Raised
$560M
Company Overview
Valo Health is a biotechnology company that leverages human-centric data and artificial intelligence through its Opal Computational Platform to streamline and accelerate the drug discovery and development process.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valo Health Comparables
Compare Valo Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insitro | 90% | |
| Insilico Medicine | 87% | |
| Iambic Therapeutics | 86% |
For institutional investors. Book with your work email.
Valo Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 8, 2025 | ||||
| Series C | Oct 28, 2022 | ||||
| M&A | Nov 15, 2021 | ||||
| SPAC Merger / PIPE | Jun 9, 2021 | ||||
| Series B | Mar 9, 2021 | ||||
Series B | Jan 11, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Valo Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Debt |
| Global Founders Capital | Series C |
| Khosla Ventures | SPAC Merger / PIPE, M&A, Series B |
| MissionBlue Capital Partners | Series B |
| Longevity Vision Fund | SPAC Merger / PIPE, Series C, M&A |
| Public Sector Pension Investment Board | SPAC Merger / PIPE, Series A, M&A, Series B |
| CAZ Investments | SPAC Merger / PIPE, M&A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Karin Conde-Knape appointed as the new Chief Scientific Officer.
- Dec 2, 2025
Rita Kale appointed as Chief Financial Officer.
For institutional investors. Book with your work email.
Valo Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Valo Health's valuation, stock price, and market status.
Is Valo Health a public or private company?
Valo Health is a private company.
What is the current stock price of Valo Health?
Valo Health is a private company, so its shares have no public market price. Caplight tracks Valo Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Valo Health worth (valuation)?
Valo Health's valuation is estimated at $2.8B based on funding round data.
Can I buy Valo Health stock?
Valo Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Valo Health's last funding round?
Valo Health's most recent funding round was Strategic on January 8, 2025.
Who are the main investors in Valo Health?
Key investors in Valo Health include Hercules Capital, Public Sector Pension Investment Board, Koch Disruptive Technologies, Flagship Pioneering, Koch Disruptive Technologies.
Will Valo Health IPO soon?
No public IPO plans have been announced for Valo Health.
How can I track Valo Health secondary market activity?
Caplight tracks bids, offers, and trades in Valo Health's shares on secondary markets.